The civic record
Read. Follow. Verify.Louisiana House Bill 203 adds Christus Health System Xavier Ochsner College of Medicine member to Uterine Fibroids Commission
Last action · May 22, 2026: Effective date: 08/01/2026.Sponsor: Joy Walters
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
Louisiana HB 203 updates the membership of the Uterine Fibroids Commission to include one representative from the Christus Health System Xavier Ochsner College of Medicine, effective August 1, 2026.
The change alters the organizational representation on a state medical commission by adding a specific medical college seat, influencing the composition of bodies advising on uterine fibroids research and care.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Uterine Fibroids Commission
The commission gains an additional designated member seat representing the Christus Health System Xavier Ochsner College of Medicine.
Christus Health System Xavier Ochsner College of Medicine
The institution gains official representation with one member appointed to the Uterine Fibroids Commission.
Key Facts
- House Bill 203 amends R.S. 40:1104(B)(3) regarding the Uterine Fibroids Commission.
- The commission is updated to include one member from the Christus Health System Xavier Ochsner College of Medicine.
- The law takes effect on August 1, 2026.
Frequently Asked Questions
What change does House Bill 203 make to the Uterine Fibroids Commission?
When does this change take effect?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Current status: Signed into law.
Procedural history
20 actions- May 22, 2026HouseEnrolledSigned by the Governor. Becomes Act No. 292.
- May 22, 2026HouseEffective date: 08/01/2026.
- May 19, 2026HouseReceived from the Senate without amendments.
- May 19, 2026HouseEnrolledEnrolled and signed by the Speaker of the House.
- May 19, 2026SenateEnrolledSigned by the President of the Senate.
- May 19, 2026HouseSent to the Governor for executive approval.
Show 14 earlier actions
- May 18, 2026SenateFloorRules suspended. Read by title, passed by a vote of 36 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
- May 11, 2026SenateFloorReported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
- May 7, 2026SenateIntroducedRead by title and referred to the Legislative Bureau.
- May 6, 2026SenateCommitteeReported favorably.
- Mar 30, 2026SenateCommitteeRead second time by title and referred to the Committee on Health and Welfare.
- Mar 25, 2026HouseFloorRead third time by title, roll called on final passage, yeas 98, nays 0. Finally passed, title adopted, ordered to the Senate.
- Mar 25, 2026SenateReceived in the Senate. Read first time by title and placed on the Calendar for a second reading.
- Mar 23, 2026HouseFloorRead by title, ordered engrossed, passed to 3rd reading.
- Mar 23, 2026HouseScheduled for floor debate on 03/25/2026.
- Mar 18, 2026HouseCommitteeReported favorably (8-0).
- Mar 9, 2026HouseIntroducedRead by title, under the rules, referred to the Committee on Health and Welfare.
- Feb 20, 2026HouseFirst appeared in the Interim Calendar on 2/20/2026.
- Feb 19, 2026HousePrefiled.
- Feb 19, 2026HouseCommitteeUnder the rules, provisionally referred to the Committee on Health and Welfare.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
www.legis.la.gov
Analysis Score
0–100- Significance20How much this matters to a regular citizen
- Controversy5Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools
